Roundhill GLP-1 & Weight Loss ETF (OZEM)
$29.93
▼ -0.26 (-0.85%)
1-day change
$27.34 – $37.15
52-week range
Holdings data is not available for this fund yet.
OZEM Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Performance as of Oct. 2, 2026
| Period | Price return | Total return |
|---|---|---|
| 1M | ▼ -9.71% | ▼ -9.71% |
| 3M | ▼ -6.84% | ▼ -6.84% |
| 6M | ▼ -6.84% | ▼ -6.84% |
| YTD | ▼ -12.37% | ▼ -12.37% |
| 1Y | ▲ +5.15% | ▲ +6.38% |
| 3Y | · | · |
| 5Y | · | · |
| Max | ▲ +17.99% | ▲ +19.62% |
Volatility 1Y24.29%
Volatility 3Y·
Max drawdown 3Y
·
Beta 3Y·
Sharpe 1Y*0.49
Total return assumes dividends are reinvested. Returns are not benchmarked against an index. * Sharpe ratio is computed with a 0% risk-free rate.
Fund flows (SEC-reported)
Last month (Jun 2026)
+$2.8M
Quarter ending Jun 2026
+$286K
Trailing 12 months
+$13.2M
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Full composition 26 holdings
| Name | CUSIP | Value | % | Balance | Category | Country |
|---|---|---|---|---|---|---|
| Novo Nordisk A/S | 670100205 | $7.0M | 12.96 | 146,234 | EC | DK |
| Eli Lilly & Co | 532457108 | $6.9M | 12.69 | 5,722 | EC | US |
| Mount Vernon Liquid Assets Portfolio, LLC | · | $5.4M | 9.93 | 5,371,409 | STIV | US |
| Pfizer Inc | 717081103 | $3.5M | 6.38 | 143,389 | EC | US |
| Kailera Therapeutics Inc | 482931102 | $3.4M | 6.21 | 152,501 | EC | US |
| Viking Therapeutics Inc | 92686J106 | $3.2M | 5.86 | 81,186 | EC | US |
| CSPC Pharmaceutical Group Ltd | · | $2.9M | 5.32 | 3,236,000 | EC | CN |
| Chugai Pharmaceutical Co Ltd | · | $2.4M | 4.51 | 52,600 | EC | JP |
| Ascletis Pharma Inc | · | $2.3M | 4.20 | 1,686,000 | EC | CN |
| Zealand Pharma A/S | · | $2.1M | 3.92 | 47,873 | EC | DK |
| Amgen Inc | 031162100 | $2.1M | 3.85 | 5,750 | EC | US |
| AstraZeneca PLC | · | $2.1M | 3.83 | 10,931 | EC | GB |
| Hanmi Pharm Co Ltd | · | $1.9M | 3.50 | 7,386 | EC | KR |
| Structure Therapeutics Inc | 86366E106 | $1.7M | 3.05 | 30,773 | EC | US |
| Roche Holding AG | · | $1.6M | 3.03 | 3,972 | EC | CH |
| MBX Biosciences Inc | 55287L101 | $1.5M | 2.80 | 27,421 | EC | US |
| UNITED LAB | · | $1.4M | 2.63 | 1,322,000 | EC | HK |
| Jiangsu Hengrui Pharmaceutical | · | $1.4M | 2.58 | 189,200 | EC | CN |
| Hansoh Pharmaceutical Group Co | · | $1.4M | 2.54 | 364,000 | EC | CN |
| Innovent Biologics Inc | · | $1.3M | 2.36 | 126,000 | EC | CN |
| Gubra A/S | · | $1.0M | 1.87 | 20,597 | EC | DK |
| Gilead Sciences Inc | 375558103 | $938K | 1.73 | 7,425 | EC | US |
| Rhythm Pharmaceuticals Inc | 76243J105 | $884K | 1.64 | 7,966 | EC | US |
| Shionogi & Co Ltd | · | $671K | 1.24 | 39,100 | EC | JP |
| WaVe Life Sciences Ltd | · | $467K | 0.86 | 80,432 | EC | SG |
| First American Government Obli | 31846V336 | $335K | 0.62 | 335,006 | STIV | US |
Dividends 2 payments
1.37%TTM yield
$0.41TTM payout / share
Annual
(est.)
| Ex-date | Amount / share |
|---|---|
| Dec. 30, 2025 | $0.4100 |
| Dec. 30, 2024 | $0.0530 |
Institutional owners (13F) 26 filers
Institutions that report holding this ETF in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| Institution | Value | % of tracked 13F | Shares | Type | As of |
|---|---|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1,414,579 | 13.12% | 43,472 | Shares | June 30, 2026 |
| Cox Capital Mgt LLC | $1,314,356 | 12.19% | 40,392 | Shares | June 30, 2026 |
| COMMONWEALTH EQUITY SERVICES, LLC | $1,193,120 | 11.07% | 36,666 | Shares | June 30, 2026 |
| OAK FAMILY ADVISORS, LLC | $972,686 | 9.02% | 29,892 | Shares | June 30, 2026 |
| Perigon Wealth Management, LLC | $822,286 | 7.63% | 25,270 | Shares | June 30, 2026 |
| PRINCIPAL SECURITIES, INC. | $820,594 | 7.61% | 25,218 | Shares | June 30, 2026 |
| ENVESTNET ASSET MANAGEMENT INC | $762,022 | 7.07% | 23,418 | Shares | June 30, 2026 |
| CITADEL ADVISORS LLC | $637,784 | 5.92% | 19,600 | Put option | June 30, 2026 |
| Summit Financial, LLC | $572,509 | 5.31% | 17,594 | Shares | June 30, 2026 |
| OSAIC HOLDINGS, INC. | $474,346 | 4.40% | 14,578 | Shares | June 30, 2026 |
| UBS Group AG | $392,432 | 3.64% | 12,060 | Shares | June 30, 2026 |
| Arrowroot Family Office, LLC | $348,471 | 3.23% | 10,709 | Shares | June 30, 2026 |
| WOLVERINE TRADING, LLC | $347,842 | 3.23% | 13,000 | Put option | Sept. 30, 2025 |
| LODESTAR PRIVATE ASSET MANAGEMENT LLC | $342,679 | 3.18% | 10,531 | Shares | June 30, 2026 |
| TRUIST FINANCIAL CORP | $233,279 | 2.16% | 7,169 | Shares | June 30, 2026 |
| BANK OF MONTREAL /CAN/ | $35,469 | 0.33% | 1,090 | Shares | June 30, 2026 |
| MORGAN STANLEY | $33,809 | 0.31% | 1,039 | Shares | June 30, 2026 |
| Rockefeller Capital Management L.P. | $16,270 | 0.15% | 500 | Shares | June 30, 2026 |
| CWM, LLC | $15,600 | 0.14% | 500 | Shares | March 31, 2026 |
| Farther Finance Advisors, LLC | $9,274 | 0.09% | 285 | Shares | June 30, 2026 |
| HOLLENCREST CAPITAL MANAGEMENT | $4,425 | 0.04% | 136 | Shares | June 30, 2026 |
| ROYAL BANK OF CANADA | $4,000 | 0.04% | 137 | Shares | June 30, 2026 |
| Federation des caisses Desjardins du Quebec | $3,254 | 0.03% | 100 | Shares | June 30, 2026 |
| Fourth Dimension Wealth, LLC | $3,254 | 0.03% | 100 | Shares | June 30, 2026 |
| AdvisorNet Financial, Inc | $2,761 | 0.03% | 85 | Shares | June 30, 2026 |
| Physician Wealth Advisors, Inc. | $1,302 | 0.01% | 40 | Shares | June 30, 2026 |